ストックスクリーナーアプリを入手
0.3034
6.27%
-0.0203
プレマーケット:
.30
-0.0034
-1.12%
前日終値:
$0.3237
開ける：
$0.2948
24時間の取引高:
8.06M
Relative Volume:
0.70
時価総額：
$4.94M
収益：
$466.90K
当期純損益:
$-19.82M
株価収益率:
-0.1062
EPS:
-2.8575
ネットキャッシュフロー:
$-5.90M
1週間 パフォーマンス:
-24.15%
1か月 パフォーマンス:
-42.04%
6か月 パフォーマンス:
-87.51%
1年 パフォーマンス:
-93.61%
1日の値動き範囲:
$0.2721
$0.3205
1週間の範囲:
$0.162
$0.4128
52週間の値動き範囲:
$0.162
$4.99
Mangoceuticals Inc Stock (MGRX) Company Profile
名前
Mangoceuticals Inc
セクター
電話
(833) 626-4679
住所
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, TEM, BTSG, HQY, WAY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.3034 | 4.94M | 466.90K | -19.82M | -5.90M | -2.8575 |
VEEV
Veeva Systems Inc
|
179.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
48.83 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Mangoceuticals Inc (MGRX) 最新ニュース
Risks Report: How does Mangoceuticals Inc perform in inflationary periods2026 Patterns & Smart Money Movement Tracker - baoquankhu1.vn
MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume - Meyka
Mag Mile Capital (OTCQB: MMCP) Surges 365% as CRE Financing Pipeline Expands Across Key Sectors - marketscreener.com
Mangoceuticals (MGRX) Stock Rockets 130% Following CEO’s Substantial Share Award - MEXC
Mangoceuticals (MGRX) Stock Surges 130% After CEO Lands 500K Share Bonus - MEXC
Mangoceuticals Inc (MGRX) Stock Price, Quote, News & History - Benzinga
Mangoceuticals Stock Doubles After Texas Lawsuit - Benzinga
Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today? - TipRanks
Setup Watch: Is Mangoceuticals Inc a good ESG investmentShare Buyback & Growth Oriented Trading Recommendations - baoquankhu1.vn
Layoff Watch: Can Mangoceuticals Inc ride the EV waveWeekly Investment Recap & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Mangoceuticals stock skyrockets 50% Friday: What's driving the rally? - MSN
Mangoceuticals (MGRX) CEO gets 2M options, bonus shares and trust note deal - Stock Titan
Mangoceuticals (MGRX) reprices CEO Jacob Cohen stock options to $0.45 - Stock Titan
MGRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Mangoceuticals files $73 million lawsuit against tech vendor By Investing.com - Investing.com South Africa
Mangoceuticals files civil lawsuit against Clarity Ventures - TipRanks
Mangoceuticals Files $73 Million Lawsuit Against Clarity Ventures Over Alleged Contract Breach - geneonline.com
Mangoceuticals Sues Former Tech Partner Over Platform Dispute - TipRanks
Mangoceuticals announces lawsuit seeking damages exceeding $73 million against Clarity Ventures - marketscreener.com
Mangoceuticals files $73 million lawsuit against tech vendor - Investing.com
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Clarity Ventures - TradingView
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. - The Manila Times
Jacob Cohen option repricing at Mango - TradingView
Mangoceuticals (NASDAQ: MGRX) reprices CEO options and pursues $73M Clarity lawsuit - Stock Titan
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding - GlobeNewswire
Mangoceuticals plunges after denying Lilly, Novo partnerships - MSN
Mangoceuticals files to sell 4.46M shares of common stock by selling shareholders - MSN
Mangoceuticals stock surges on early success of subscription TRT model - MSN
Merger Talk: Is Mangoceuticals Inc stock a top performer YTD2026 Retail Activity & Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug Breakouts: Can Mangoceuticals Inc ride the EV wave2026 Earnings Surprises & Weekly High Return Stock Opportunities - baoquankhu1.vn
MGRX PE Ratio & Valuation, Is MGRX Overvalued - Intellectia AI
Mangoceuticals, Cube Group partner for up to $100M Solana-focused DAT strategy - MSN
Analyst Downgrade: Can Mangoceuticals Inc expand into new marketsEarnings Recap Report & Reliable Volume Spike Alerts - baoquankhu1.vn
Mangoceuticals, Inc. Files International Patent Application for Innovative Antiviral Feed Additive Technology MGX-0024 - Quiver Quantitative
Mangoceuticals, Inc. announces percent patent filing for MGX-0024 antiviral technology to include inhibiting respiratory or orally acquired virus infection in animals or birds - marketscreener.com
Mangoceuticals, Inc. Announces Pct Patent Filing for Mgx-0024 Antiviral Technology - marketscreener.com
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Zero respiratory deaths in 29,000 birds sparks global patent bid - Stock Titan
Mangoceuticals' MGX-0024 Achieves 100% Survival in 29,000-Bird Studies—A Turning Point for Biosecurity? - Bitget
MGRX Earnings History & Surprises | EPS & Revenue Results | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
Aug Closing: Is Mangoceuticals Inc a momentum stockJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
MGRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Institution Moves: Can Mangoceuticals Inc deliver consistent dividendsWeekly Stock Analysis & Community Consensus Trade Signals - baoquankhu1.vn
MGRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MGRXMangoceuticals, Inc. Latest Stock News & Market Updates - Stock Titan
MGRX Should I Buy - Intellectia AI
Can Mangoceuticals Inc ride the EV waveJuly 2025 Earnings & Free Community Supported Trade Ideas - baoquankhu1.vn
Mangoceuticals reports data on antiviral compound for poultry By Investing.com - Investing.com India
Mangoceuticals' MGX-0024 achieves zero respiratory-related mortality, shows H5N1 prophylactic benefit - marketscreener.com
Mangoceuticals’ MGX-0024 Achieves Zero Respiratory-Related Mortality, Shows H5n1 Prophylactic Benefit - TradingView
Mangoceuticals Highlights Promising MGX-0024 Poultry Antiviral Data - TipRanks
Mangoceuticals Inc (MGRX) 財務データ
収益
当期純利益
現金流量
EPS
3.50%
2.28%
大文字化:
|
ボリューム (24 時間):